Evidence map›Paper›PMID 40519537›Full record

ArticleFrontiers in nuclear medicine2025

Carrie Richardson, Mehrbod S Javadi, Ami A Shah, Caoilfhionn Connolly, Lilja B Solnes, Fredrick M Wigley, Laura K Hummers, Lisa Christopher-Stine

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Carrie RichardsonDivision of Rheumatology, Johns Hopkins University, Baltimore, MD, United States.
Mehrbod S JavadiDepartment of Radiology, Johns Hopkins University, Baltimore, MD, United States.
Ami A ShahDivision of Rheumatology, Johns Hopkins University, Baltimore, MD, United States.
Caoilfhionn ConnollyDivision of Rheumatology, Johns Hopkins University, Baltimore, MD, United States.
Lilja B SolnesDepartment of Radiology, Johns Hopkins University, Baltimore, MD, United States.
Fredrick M WigleyDivision of Rheumatology, Johns Hopkins University, Baltimore, MD, United States.
Laura K HummersDivision of Rheumatology, Johns Hopkins University, Baltimore, MD, United States.
Lisa Christopher-StineDivision of Rheumatology, Johns Hopkins University, Baltimore, MD, United States.

Funding

Harnessing multivariate patient- and population-level disease trajectories to predict major clinical events in sclerodermaK24AR080217 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI Ami Aalok Shah · 2022 to 2026
$847k
NIAMS NIH HHS K24 AR080217
6 · The paper itself

Abstract

Background: Calcinosis is a morbid complication of dermatomyositis (DM) and systemic sclerosis (SSc) with no effective pharmacologic treatment or validated whole-body assessment modality. Methods: In this pilot study, we enrolled three adults with DM and three with SSc, all with new calcinosis deposits. Each underwent Results: Calcinosis was noted on Conclusions:

Indexed as

18F-NaF PET/CTcalcinosisdermatomyositisimagingscleroderma (or systemic sclerosis)

Identifiers

PMID40519537
PMCPMC12162990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.